First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Hits New 52-Week High – Here’s Why

Posted by Kim Johansen on Nov 6th, 2026

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH – Get Free Report)’s stock price reached a new 52-week high during trading on Wednesday. The stock traded as high as $44.83 and last traded at $44.3310, with a volume of 16,407 shares trading hands. The stock had previously closed at $43.87.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

The company has a market capitalization of $1.16 billion, a price-to-earnings ratio of 14.51 and a beta of 0.45. The stock has a 50 day simple moving average of $41.80 and a two-hundred day simple moving average of $37.40.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Thursday, September 24th were issued a $0.0113 dividend. This represents a $0.05 dividend on an annualized basis and a dividend yield of 0.1%. The ex-dividend date was Thursday, September 24th. This is a decrease from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.0920.

Institutional Investors Weigh In On First Trust Nasdaq Pharmaceuticals ETF

Hedge funds and other institutional investors have recently made changes to their positions in the business. Oppenheimer & Co. Inc. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter worth approximately $6,014,000. D.A. Davidson & CO. acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at $3,702,000. Cyndeo Wealth Partners LLC acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at $1,524,000. Davis Investment Partners LLC acquired a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at $1,344,000. Finally, Trust Co. of Oklahoma purchased a new position in shares of First Trust Nasdaq Pharmaceuticals ETF in the 3rd quarter valued at $1,283,000.

About First Trust Nasdaq Pharmaceuticals ETF

(Get Free Report)

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.